Literature DB >> 12140782

A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19.

R F Badenhop1, M J Moses, A Scimone, P B Mitchell, K R Ewen-White, A Rosso, J A Donald, L J Adams, P R Schofield.   

Abstract

Bipolar affective disorder is a severe mood disorder that afflicts approximately 1% of the population worldwide. Twin and adoption studies have indicated that genetic factors contribute to the disorder and while many chromosomal regions have been implicated, no susceptibility genes have been identified. We undertook a combined analysis of 10 cM genome screen data from a single large bipolar affective disorder pedigree, for which we have previously reported linkage to chromosome 13q14 (Badenhop et al, 2001) and 12 pedigrees independently screened using the same 400 microsatellite markers. This 13-pedigree cohort consisted of 231 individuals, including 69 affected members. Two-point LOD score analysis was carried out under heterogeneity for three diagnostic and four genetic models. Non-parametric multipoint analysis was carried out on regions of interest. Two-point heterogeneity LOD scores (HLODs) greater than 1.5 were obtained for 11 markers across the genome, with HLODs greater than 2.0 obtained for four of these markers. The strongest evidence for linkage was at 3q25-26 with a genome-wide maximum score of 2.49 at D3S1279. Six markers across a 50 cM region at 3q25-26 gave HLODs greater than 1.5, with three of these markers producing scores greater than 2.0. Multipoint analysis indicated a 20 cM peak between markers D3S1569 and D3S1614 with a maximum NPL of 2.8 (P= 0.004). Three other chromosomal regions yielded evidence for linkage: 9q31-q33, 13q14 and 19q12-q13. The regions on chromosomes 3q and 13q have previously been implicated in other bipolar and schizophrenia studies. In addition, several individual pedigrees gave LOD scores greater than 1.5 for previously reported bipolar susceptibility loci on chromosomes 18p11, 18q12, 22q11 and 8p22-23.

Entities:  

Mesh:

Year:  2002        PMID: 12140782     DOI: 10.1038/sj.mp.4001025

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  4 in total

1.  Genomewide scan for affective disorder susceptibility Loci in families of a northern Swedish isolated population.

Authors:  Tine Venken; Stephan Claes; Samuel Sluijs; Andrew D Paterson; Cornelia van Duijn; Rolf Adolfsson; Jurgen Del-Favero; Christine Van Broeckhoven
Journal:  Am J Hum Genet       Date:  2004-12-21       Impact factor: 11.025

2.  A genome-wide association study of bipolar disorder with comorbid eating disorder replicates the SOX2-OT region.

Authors:  Xiaohua Liu; John R Kelsoe; Tiffany A Greenwood
Journal:  J Affect Disord       Date:  2015-09-25       Impact factor: 4.839

3.  GSK-3β polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis.

Authors:  Hui Tang; Na Shen; Huijuan Jin; Dan Liu; Xiaoping Miao; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2013-02-27       Impact factor: 5.590

4.  Pedigree with frontotemporal lobar degeneration--motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9.

Authors:  Agnes A Luty; John B J Kwok; Elizabeth M Thompson; Peter Blumbergs; William S Brooks; Clement T Loy; Carol Dobson-Stone; Peter K Panegyres; Jane Hecker; Garth A Nicholson; Glenda M Halliday; Peter R Schofield
Journal:  BMC Neurol       Date:  2008-08-29       Impact factor: 2.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.